ZA
SMERCO
KMRHAFPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Caribou Biosciencescariboubio.com  KCPMKM |
Caribou Biosciences is a clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic CAR-T cell therapies using | Berkeley, California | 51-200 | — |
Allogene Therapeuticsallogene.com  M( SKMC |
Allogene Therapeutics is a clinical-stage biotechnology company developing investigational allogeneic chimeric antigen receptor T | South San Francisco, California | 201-1000 | — |
2seventy bio2seventybio.com |
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies, operating from Cambridge, Ma | Cambridge, Massachusetts | 201-1000 | — |
Intelliatxintelliatx.com  KSJW JD |
Intellia Therapeutics is a clinical-stage biopharmaceutical company developing CRISPR-based gene editing therapies to treat severe | Cambridge, Massachusetts | 201-1000 | — |
Editas Medicineeditasmedicine.com  DCOA LC |
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipel | Cambridge, Massachusetts | 51-200 | — |
CRISPR Therapeuticscrisprtx.com  HNBW KB |
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever appr | Boston, Massachusetts | 201-1000 | — |
Abintusbioabintusbio.com |
Abintus is a biotechnology company pioneering in vivo genetic medicines that engineer cells directly inside the patient's body usi | San Diego, California | 1-10 | — |
Tome Biosciencestome.bio |
Tome Biosciences is a biotechnology company developing programmable gene insertion technology, founded in 2021 and based in Cambri | Cambridge, Massachusetts | 51-200 | — |
Atara Biotherapeuticsatarabio.com SSASAS |
Atara Biotherapeutics is an allogeneic T-cell immunotherapy company developing off-the-shelf T-cell therapies for patients with ca | Thousand Oaks, California | 51-200 | — |
A2 Biotherapeuticsa2biotherapeutics.com |
A2 Biotherapeutics is a cell therapy company focused on treating solid tumors, engineering T cells that target the loss of genetic | Agoura Hills, California | 51-200 | — |
Omega Therapeuticsomegatherapeutics.com  MG HB PM |
Omega Therapeutics is a clinical-stage biotechnology company in Cambridge, Massachusetts, pioneering the OMEGA platform — a system | Cambridge, Massachusetts | 11-50 | — |
Centurytxcenturytx.com  PD AM MF |
Century Therapeutics is an allogeneic, iPSC-derived cell therapy company developing CNTY-813, a beta islet cell replacement therap | Philadelphia, Pennsylvania | 51-200 | — |
IASO Bioiasobio.com YWCS  CS |
IASO Bio is a commercial-stage biopharmaceutical company founded in 2017 in Shanghai that develops cell therapies and biologics fo | Shanghai, Shanghai | 51-200 | — |
Arbor Biotechnologiesarbor.bio  LLJCAL |
Arbor Biotechnologies is a next-generation gene editing company based in Cambridge, Massachusetts, developing potentially curative | Cambridge, Massachusetts | 51-200 | — |
Scribe Therapeuticsscribetx.com  TZ NKMC |
Scribe Therapeutics is a CRISPR-based genetic medicine company founded in 2017 by Nobel laureate Jennifer A. Doudna and CRISPR pio | Alameda, California | 51-200 | — |
Gate Biosciencegatebio.com |
Gate Bioscience is a preclinical biotechnology company developing Molecular Gates — small molecule drugs that bind to the secretor | Brisbane, California | 11-50 | — |
Mammoth Biosciencesmammoth.bio |
Mammoth Biosciences is a biotechnology company developing in vivo CRISPR-based gene editing therapeutics and CRISPR-based diagnost | Brisbane, California | 51-200 | — |
Beam Therapeuticsbeamtx.com |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
A2Bioa2bio.com |
A2 is a biotechnology company developing cell therapies that target solid tumors, the next frontier in cancer treatment. Founded i | Agoura Hills, California | 51-200 | — |
ImmuneCyteimmunecyte.com |
ImmuneCyte is a clinical-stage biopharmaceutical company developing fourth-generation chimeric antigen receptor (CAR)-T cell, CAR- | Irvine, California | 51-200 | — |
Kano Therapeuticskanotherapeutics.com |
Kano Therapeutics is a biotech startup in Cambridge, Massachusetts that builds a platform of circular single-stranded DNA biomater | Cambridge, Massachusetts | 11-50 | — |
Metagenomimetagenomi.co |
Metagenomi is a precision genetic medicines company developing curative therapeutics using a proprietary metagenomics-derived geno | Emeryville, California | 51-200 | — |
Cabaletta Biocabalettabio.com |
Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company developing engineered T cell therapies for autoimmune disea | Philadelphia, Pennsylvania | 51-200 | — |
Appia Bioappiabio.com |
Appia Bio is an early-stage biotechnology company founded in 2020 in Los Angeles, California, focused on discovering and developin | Culver City, California | 11-50 | — |
Arsenal Biosciencesarsenalbio.com |
Arsenal Biosciences is a clinical-stage, programmable cell therapy company developing solid tumor cell therapies to defeat cancer, | South San Francisco, California | 51-200 | — |
ImmPACT Bio USAimmpact-bio.com |
ImmPACT Bio USA is a biotechnology company developing novel cell therapies for treating cancer, founded in 2017 and headquartered | west hills, California | 51-200 | — |
Artiva Biotherapeuticsartivabio.com |
Artiva Biotherapeutics is a clinical-stage biotechnology company developing AlloNK®, a non-genetically modified, cryopreserved all | San Diego, California | 51-200 | — |
Arcellxarcellx.com |
Arcellx (now part of Kite, a Gilead company) is a biotechnology research firm founded in 2015 that developed Anito-cel, a cell the | Redwood City, California | 201-1000 | — |
Cellinfinity Biocellinfinitybio.com |
Cellinfinity Bio is a biotechnology company developing proprietary technologies that open near-infinite possibilities of cell ther | West Haven, Connecticut | 1-10 | — |
Capstan Therapeuticscapstantx.com |
Capstan Therapeutics is a biotechnology company advancing cell engineering to develop therapeutics for a broad range of diseases, | San Diego, California | 51-200 | — |
| Run live for more | ||||
Caribou Biosciences is a clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic CAR-T cell therapies using its patented chRDNA CRISPR genome-editing technology, targeting patients with hematologic malignancies.
Companies like Caribou Biosciences include Allogene Therapeutics, 2seventy bio, Intelliatx, Editas Medicine, CRISPR Therapeutics. See the full list of 24 competitors and alternatives above.
Caribou Biosciences has approximately 51-200 employees and is in the Biotechnology Research industry.
Caribou Biosciences is headquartered in Berkeley, California.
Caribou Biosciences operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Caribou Biosciences are listed above, including leaders across executive, finance, sales and operations.